Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

J Thromb Haemost. 2006 Jan;4(1):256-7. doi: 10.1111/j.1538-7836.2005.01666.x.

Authors

R M Bertina¹, N H van Tilburg, F Haverkate, B N Bouma, P A K von dem Borne, J C M Meijers, W Campbell, D Eaton, D F Hendriks, J L Willemse

Affiliation

¹ Hemostasis and Thrombosis Research Centre, Department of Hematology, Leiden University Medical Centre, Leiden, The Netherlands. r.m.bertina@lumc.nl

PMID: 16409476
DOI: 10.1111/j.1538-7836.2005.01666.x

No abstract available

Publication types

Comment
Historical Article

MeSH terms

Carboxypeptidase B2 / antagonists & inhibitors
Carboxypeptidase B2 / history*
Carboxypeptidase B2 / physiology
Fibrinolysis
History, 20th Century
History, 21st Century
Humans
Protein C / physiology
Tissue Plasminogen Activator / physiology

Substances

Protein C
Carboxypeptidase B2
Tissue Plasminogen Activator